Hi All,
Two recent developments... In mid-November I met with the Rad-Onc at UMDNJ-Robert Wood Johnson Medical School. He told me the risks and benefits of radiotherapy and told me that he does only paraaortic for seminoma, but he also appeared comfortable with surveillance for my particular case.
Last week, on November 30th, I finally made it to Sloan-Kettering for a second opinion on my scans and pathology. The experience was as many here have described. Until now, I was always in waiting rooms with men and women much older than I, and at SK nearly everyone was a relatively young guy. Most seemed in pretty good spirits, some seemed somber... Lots and lots of people in the waiting room. I eventually (briefly) saw Dr. Sheinfeld. He reviewed my scans and arranged for a pathologist to review the slides that I had brought. He was the first Doctor that actually said "I think you'll be fine", but he was also strongly in favor of radiotherapy. He too, told me of the risks, but felt they were minimal relative to the benefit. I've been struggling with this ever since, but I'm still leaning towards surveillance. He mentioned that the final outcome should be the same, either way, but he hates the odds of recurrence without radiotherapy. He also insisted that if I were to do radiotherapy with them, it would be "dog-leg" so that's including the pelvic region.
After leaving SK, I decided that I would make my final decision with the SK path report, feeling that if they saw LV invasion, I would probably go with the radiotherapy.
I got that report today... everything was identical to my original...NO LV invasion observed (yay). However, no mention of the intertubular GCN was made that was on the original (while inTRAtubular GCN was mentioned). Also, they estimated the tumor to be 2.1 cm in it's largest dimension, as opposed to the 1.5 cm that the original report claimed. When I had measured it on the slide, I saw that it was 1.5 cm as well, so I'm wondering if SK uses different criteria. Also, SK path report mentions the rete testis (no involvement) but says that the "tumor abuts the rete testis".
Oh well, I guess it leaves me still torn. Xmas is coming up, and my first CT scan is set for Feburary 20th, at this point I'm just as inclined to stay the current course of surveillance...
Regards,
djm
Two recent developments... In mid-November I met with the Rad-Onc at UMDNJ-Robert Wood Johnson Medical School. He told me the risks and benefits of radiotherapy and told me that he does only paraaortic for seminoma, but he also appeared comfortable with surveillance for my particular case.
Last week, on November 30th, I finally made it to Sloan-Kettering for a second opinion on my scans and pathology. The experience was as many here have described. Until now, I was always in waiting rooms with men and women much older than I, and at SK nearly everyone was a relatively young guy. Most seemed in pretty good spirits, some seemed somber... Lots and lots of people in the waiting room. I eventually (briefly) saw Dr. Sheinfeld. He reviewed my scans and arranged for a pathologist to review the slides that I had brought. He was the first Doctor that actually said "I think you'll be fine", but he was also strongly in favor of radiotherapy. He too, told me of the risks, but felt they were minimal relative to the benefit. I've been struggling with this ever since, but I'm still leaning towards surveillance. He mentioned that the final outcome should be the same, either way, but he hates the odds of recurrence without radiotherapy. He also insisted that if I were to do radiotherapy with them, it would be "dog-leg" so that's including the pelvic region.
After leaving SK, I decided that I would make my final decision with the SK path report, feeling that if they saw LV invasion, I would probably go with the radiotherapy.
I got that report today... everything was identical to my original...NO LV invasion observed (yay). However, no mention of the intertubular GCN was made that was on the original (while inTRAtubular GCN was mentioned). Also, they estimated the tumor to be 2.1 cm in it's largest dimension, as opposed to the 1.5 cm that the original report claimed. When I had measured it on the slide, I saw that it was 1.5 cm as well, so I'm wondering if SK uses different criteria. Also, SK path report mentions the rete testis (no involvement) but says that the "tumor abuts the rete testis".
Oh well, I guess it leaves me still torn. Xmas is coming up, and my first CT scan is set for Feburary 20th, at this point I'm just as inclined to stay the current course of surveillance...
Regards,
djm
Comment